Page last updated: 2024-09-05

deferasirox and Long QT Syndrome

deferasirox has been researched along with Long QT Syndrome in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Balez, S; Dumortier, T; Sechaud, R	1

Trials

1 trial(s) available for deferasirox and Long QT Syndrome

Article	Year
Deferasirox does not induce QT/QTc-prolongation in healthy subjects. International journal of clinical pharmacology and therapeutics, 2009, Volume: 47, Issue:5 Topics: Adolescent; Adult; Aged; Area Under Curve; Aza Compounds; Benzoates; Deferasirox; Dose-Response Relationship, Drug; Double-Blind Method; Electrocardiography; Female; Fluoroquinolones; Humans; Iron Chelating Agents; Long QT Syndrome; Male; Middle Aged; Moxifloxacin; Quinolines; Triazoles; Young Adult	2009

Article

Year

Deferasirox does not induce QT/QTc-prolongation in healthy subjects.

International journal of clinical pharmacology and therapeutics, 2009, Volume: 47, Issue:5

Topics: Adolescent; Adult; Aged; Area Under Curve; Aza Compounds; Benzoates; Deferasirox; Dose-Response Relationship, Drug; Double-Blind Method; Electrocardiography; Female; Fluoroquinolones; Humans; Iron Chelating Agents; Long QT Syndrome; Male; Middle Aged; Moxifloxacin; Quinolines; Triazoles; Young Adult

2009